A comparative genomic analysis of oral versus laryngeal and pharyngeal cancer also found that LAMA2 (TCGA: 5% vs 19%) mutations are enriched in laryngeal and pharyngeal squamous cell carcinoma (L/P-SCC)30, while other factors are enriched in pathways such as “DNA REPLICATION” and “PYRIMIDINE METABOLISM”. Here, LAMA2 is linked to pharynx cancer.